Higher levels of von Willebrand factor in patients with syncope due to orthostatic hypotension

被引:14
|
作者
Isma, Nazim [1 ,2 ]
Sutton, Richard [3 ]
Hillarp, Andreas [4 ]
Strandberg, Karin [4 ]
Melander, Olle [2 ]
Fedorowski, Artur [1 ,2 ]
机构
[1] Lund Univ, Clin Res Ctr, Skane Univ Hosp, Dept Cardiol, Malmo, Sweden
[2] Lund Univ, Clin Res Ctr, Skane Univ Hosp, Dept Clin Sci, Malmo, Sweden
[3] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England
[4] Skane Univ Hosp, Ctr Thrombosis & Haemostasis, S-20502 Malmo, Sweden
基金
英国医学研究理事会; 欧洲研究理事会;
关键词
MALMO PREVENTIVE PROJECT; CORONARY-HEART-DISEASE; ATHEROSCLEROSIS RISK; CARDIOVASCULAR-DISEASE; PREDICTS MORTALITY; SHEAR-STRESS; COMMUNITIES; MANAGEMENT; ATTACKS; ADULTS;
D O I
10.1097/HJH.0000000000000595
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objectives: Orthostatic hypotension has been linked with increased mortality and cardiovascular morbidity; however, the underlying mechanisms are still unknown. The aim of the study was to assess markers of coagulability in patients with and without orthostatic hypotension who suffered transient loss of consciousness. Methods: A total of 233 consecutive patients more than 15 years old, with unexplained transient loss of consciousness, underwent head-up tilt test (HUT, Italian protocol). Blood samples were collected during supine rest before and at 3 min of 70 degrees HUT for determination of fibrinogen, von Willebrand factor antigen (vWF:Ag) and activity (vWF:GP1bA), factor VIII (FVIII:C), lupus anticoagulant, and functional activated protein C-resistance. Orthostatic hypotension was defined as persistent decrease in SBP and/or DBP of more than 20/10 mmHg or SBP lower than 90 mmHg during passive HUT. Results: One hundred and seventy-eight patients (81 men, 45.5%) not treated with vitamin-K antagonists were analyzed. Those with orthostatic hypotension (n = 49) were older [61 +/- 18 vs. 47 +/- 21 years (mean +/- SD), P < 0.001], had increased FVIII:C-supine (1.2 +/- 0.39 vs. 1.0 +/- 0.35, P = 0.001), FVIII:C-standing (1.2 +/- 0.36 vs. 1.0 +/- 0.34, P = 0.001), vWF:Ag-supine (1.5 +/- 0.66 vs. 1.1 +/- 0.44, P < 0.001), vWF:Ag-standing (1.5 +/- 0.67 vs. 1.1 +/- 0.46, P < 0.001), vWF:GP1bA-supine (1.5 +/- 0.73 vs. 1.1 +/- 0.42, P < 0.001), vWF:GP1bA-standing (1.5 +/- 0.75 vs. 1.1 +/- 0.42 P < 0.001), fibrinogen-standing (2.9 +/- 0.53 vs. 2.7 +/- 0.61, P = 0.03) but not fibrinogen-supine (2.8 +/- 0.54 vs. 2.7 +/- 0.61, P = 0.078) compared with patients without orthostatic hypotension. However, after adjustment for age, sex, and comorbidity, only vWF:Ag and vWF:GP1bA levels remained significantly increased in orthostatic hypotension patients. Conclusion: Concentration of vWF is elevated in patients with orthostatic hypotension who suffered a syncopal event. This observation may be helpful in understanding the increased risk of cardiovascular events in orthostatic hypotension.
引用
收藏
页码:1594 / 1601
页数:8
相关论文
共 50 条
  • [41] Familial clustering of factor VIII and von Willebrand factor levels
    Kamphuisen, PW
    Houwing-Duistermaat, JJ
    van Houwelingen, HC
    Eikenboom, JCJ
    Bertina, RM
    Rosendaal, FR
    THROMBOSIS AND HAEMOSTASIS, 1998, 79 (02) : 323 - 327
  • [42] Pharmacokinetics of von Willebrand factor (human) in patients with von Willebrand disease (vWD)
    Menache, D
    Aronson, DL
    Kennedy, D
    Montgomery, RR
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2097 - P2097
  • [43] Pharmacokinetics of a Recombinant Von Willebrand Factor in Patients with Severe Von Willebrand Disease
    Ragni, Margaret V.
    Castaman, Giancarlo
    Gill, Joan Cox
    Kouides, Peter
    Chapman, Miranda
    Sytkowski, Arthur
    Obermann-Slupetzky, Ortrun
    Presch, Isabella
    Fritsch, Sandor
    Ewenstein, Bruce M.
    BLOOD, 2015, 126 (23)
  • [44] Postpartum von Willebrand factor levels in women with and without von Willebrand disease and implications for prophylaxis
    James, A. H.
    Konkle, B. A.
    Kouides, P.
    Ragni, M. V.
    Thames, B.
    Gupta, S.
    Sood, S.
    Fletcher, S. K.
    Philipp, C. S.
    HAEMOPHILIA, 2015, 21 (01) : 81 - 87
  • [45] Ethnic variation in von Willebrand factor levels can influence the diagnosis of von Willebrand disease
    Sukhu, K
    Poovalingam, V
    Mahomed, R
    Giangrande, PLF
    CLINICAL AND LABORATORY HAEMATOLOGY, 2003, 25 (04): : 247 - 249
  • [46] von Willebrand factor antigen levels in plasma of patients with malignant breast disease
    Röhsig, LM
    Damin, DC
    Stefani, SD
    Castro, CG
    Roisenberg, I
    Schwartsmann, G
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2001, 34 (09) : 1125 - 1129
  • [47] Interpreting High Levels of Unfolded Von Willebrand Factor in Patients with the Antiphospholipid Syndrome
    De Laat-Kremers, Romy
    Huang, Shengshi
    Ten Cate, Hugo
    Ninivaggi, Marisa
    De Laat, Bas
    Devreese, Katrien M. J.
    BLOOD, 2024, 144 : 2602 - 2603
  • [48] Elevation of plasma levels of von Willebrand factor in diabetic patients with foot ulceration
    Aso, Y
    Fujiwara, Y
    Tayama, K
    Inukai, T
    Takemura, Y
    DIABETES, 2001, 50 : A484 - A484
  • [49] Ethnic variation in von Willebrand factor levels can influence the diagnosis of von Willebrand disease
    Fleming, AF
    CLINICAL AND LABORATORY HAEMATOLOGY, 2003, 25 (06): : 413 - 413
  • [50] Predictors of von Willebrand disease diagnosis in individuals with borderline von Willebrand factor plasma levels
    Bucciarelli, P.
    Siboni, S. M.
    Stufano, F.
    Biguzzi, E.
    Canciani, M. T.
    Mistretta, C.
    Baronciani, L.
    Lotta, L. A.
    Rosendaal, F. R.
    Peyvandi, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 944 - 944